AR051931A1 - Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes - Google Patents
Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentesInfo
- Publication number
- AR051931A1 AR051931A1 ARP050104239A ARP050104239A AR051931A1 AR 051931 A1 AR051931 A1 AR 051931A1 AR P050104239 A ARP050104239 A AR P050104239A AR P050104239 A ARP050104239 A AR P050104239A AR 051931 A1 AR051931 A1 AR 051931A1
- Authority
- AR
- Argentina
- Prior art keywords
- estrogen
- phase
- daily dose
- progestin
- regimes
- Prior art date
Links
- 230000001174 ascending effect Effects 0.000 title abstract 2
- 230000003054 hormonal effect Effects 0.000 title 1
- 229940011871 estrogen Drugs 0.000 abstract 12
- 239000000262 estrogen Substances 0.000 abstract 12
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 7
- 239000000583 progesterone congener Substances 0.000 abstract 7
- 239000003433 contraceptive agent Substances 0.000 abstract 3
- 230000002254 contraceptive effect Effects 0.000 abstract 3
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61642404P | 2004-10-07 | 2004-10-07 | |
| US68456805P | 2005-05-26 | 2005-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051931A1 true AR051931A1 (es) | 2007-02-21 |
Family
ID=36001184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104239A AR051931A1 (es) | 2004-10-07 | 2005-10-07 | Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060135496A1 (enExample) |
| EP (3) | EP1814556A2 (enExample) |
| JP (1) | JP2008515909A (enExample) |
| AR (1) | AR051931A1 (enExample) |
| AU (1) | AU2005294269B2 (enExample) |
| BR (1) | BRPI0516247A (enExample) |
| CA (1) | CA2582530A1 (enExample) |
| IL (1) | IL182287A0 (enExample) |
| MX (1) | MX2007004120A (enExample) |
| TW (1) | TW200626161A (enExample) |
| WO (1) | WO2006042021A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050032756A1 (en) * | 1995-10-28 | 2005-02-10 | Michael Dittgen | Multistage preparation for contraception based on natural estrogens |
| NZ591627A (en) * | 2001-12-05 | 2012-09-28 | Teva Womens Health Inc | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| JP2005530768A (ja) * | 2002-05-09 | 2005-10-13 | メディジーンズ | 血漿または血清を含有した創傷治療用医薬組成物 |
| CA2771944A1 (en) * | 2003-07-16 | 2005-01-27 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| US20070111975A1 (en) * | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| US8153616B2 (en) * | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| KR20090029237A (ko) | 2006-06-02 | 2009-03-20 | 피어 트리 파머슈티칼스 인코포레이티드 | 위축성 질염을 치료하는 방법 |
| EP1930010A1 (de) * | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
| US8828981B2 (en) | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
| US9192614B2 (en) | 2008-10-08 | 2015-11-24 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
| WO2010042607A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc | Transdermal delivery |
| EP2343979B1 (en) | 2008-10-08 | 2020-04-08 | Agile Therapeutics, Inc. | Transdermal delivery |
| WO2010111488A1 (en) | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4544554A (en) * | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4530839A (en) * | 1983-09-26 | 1985-07-23 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4616006A (en) * | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US5010070A (en) * | 1987-06-15 | 1991-04-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
| US4962098A (en) * | 1987-06-15 | 1990-10-09 | Warner-Lambert Company | Graduated estrogen contraceptive |
| DK174724B1 (da) | 1986-07-15 | 2003-10-06 | Wyeth Corp | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet |
| IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
| WO1998004246A2 (en) * | 1996-07-26 | 1998-02-05 | American Home Prod | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
| US6028064A (en) * | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
| US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| US6251956B1 (en) * | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
| US6214815B1 (en) * | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
| US7297688B2 (en) * | 2000-06-08 | 2007-11-20 | Wyeth | Starter kit for low dose oral contraceptives |
| NZ591627A (en) * | 2001-12-05 | 2012-09-28 | Teva Womens Health Inc | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| US20030219471A1 (en) * | 2002-03-11 | 2003-11-27 | Caubel Patrick Michel | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens |
| EP1494679A4 (en) * | 2002-04-03 | 2009-10-28 | Barr Lab Inc | STEP-BY-STEP ESTROGENTHERAPY |
| US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
| CA2771944A1 (en) * | 2003-07-16 | 2005-01-27 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| AU2004277998A1 (en) * | 2003-10-01 | 2005-04-14 | Janssen Pharmaceutica N.V. | Extended triphasic contraceptive regimens |
| US20070111975A1 (en) * | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
-
2005
- 2005-10-07 TW TW094135177A patent/TW200626161A/zh unknown
- 2005-10-07 BR BRPI0516247-5A patent/BRPI0516247A/pt not_active IP Right Cessation
- 2005-10-07 EP EP05810167A patent/EP1814556A2/en not_active Withdrawn
- 2005-10-07 EP EP10184480A patent/EP2392332A1/en not_active Withdrawn
- 2005-10-07 WO PCT/US2005/035997 patent/WO2006042021A2/en not_active Ceased
- 2005-10-07 MX MX2007004120A patent/MX2007004120A/es not_active Application Discontinuation
- 2005-10-07 AR ARP050104239A patent/AR051931A1/es unknown
- 2005-10-07 AU AU2005294269A patent/AU2005294269B2/en not_active Ceased
- 2005-10-07 CA CA002582530A patent/CA2582530A1/en not_active Abandoned
- 2005-10-07 US US11/245,471 patent/US20060135496A1/en not_active Abandoned
- 2005-10-07 JP JP2007535814A patent/JP2008515909A/ja active Pending
- 2005-10-07 EP EP10184616A patent/EP2392333A1/en not_active Withdrawn
-
2007
- 2007-03-29 IL IL182287A patent/IL182287A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006042021B1 (en) | 2006-08-03 |
| AU2005294269A1 (en) | 2006-04-20 |
| WO2006042021A2 (en) | 2006-04-20 |
| BRPI0516247A (pt) | 2008-08-26 |
| MX2007004120A (es) | 2007-06-15 |
| AU2005294269B2 (en) | 2011-07-28 |
| EP1814556A2 (en) | 2007-08-08 |
| US20060135496A1 (en) | 2006-06-22 |
| CA2582530A1 (en) | 2006-04-20 |
| WO2006042021A3 (en) | 2006-06-08 |
| EP2392332A1 (en) | 2011-12-07 |
| JP2008515909A (ja) | 2008-05-15 |
| EP2392333A1 (en) | 2011-12-07 |
| TW200626161A (en) | 2006-08-01 |
| IL182287A0 (en) | 2008-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049985A1 (es) | Tratamiento de combinacion para enfermedades malignas no hematologicas | |
| CU20110100A7 (es) | Tratamiento de pirfenidona para pacientes con función hepática atípica | |
| WO2005007112A3 (en) | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | |
| MX2009004616A (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente. | |
| CO4970819A1 (es) | Tratamiento de disfuncion sexual femenina en una hembra humana | |
| CR20110243A (es) | Tratamiento de pirfenidona para pacientes con función hepática. | |
| PE20211199A1 (es) | Uso de reboxetina para el tratamiento de narcolepsia | |
| AR020803A1 (es) | Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento | |
| AR065816A1 (es) | Regimen anticonceptivo oral | |
| ATE347358T1 (de) | Schwimmende orale formulierungen mit kontrollierter freisetzung von betain | |
| AR065582A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| BRPI0516247A (pt) | métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente | |
| AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
| AR023185A1 (es) | Tratamiento de cancer mejorado con temozolomida | |
| JP2014510780A5 (enExample) | ||
| CR8059A (es) | Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas | |
| AR039546A1 (es) | Terapia de reemplazo hormonal | |
| UY28457A1 (es) | Nueva composición | |
| CY1110321T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
| CR8010A (es) | Regimenes de contraceptivos transdermicos extendidos | |
| CO5690602A2 (es) | Regimenes anticonceptivos trifasicos extendidos | |
| AR039547A1 (es) | Terapia de reemplazo hormonal | |
| AR047154A1 (es) | Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol | |
| AR048068A1 (es) | Piperazinas derivadas de urea para el tratamiento de endometriosis | |
| CA2664300A1 (en) | Agent for preventing onset of post-stroke reflex sympathetic dystrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |